» Articles » PMID: 38409452

Transgenerational Epigenetic Inheritance of Cardiovascular Diseases: A Network Medicine Perspective

Overview
Specialty Health Services
Date 2024 Feb 27
PMID 38409452
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The ability to identify early epigenetic signatures underlying the inheritance of cardiovascular risk, including trans- and intergenerational effects, may help to stratify people before cardiac symptoms occur.

Methods: Prospective and retrospective cohorts and case-control studies focusing on DNA methylation and maternal/paternal effects were searched in Pubmed from 1997 to 2023 by using the following keywords: DNA methylation, genomic imprinting, and network analysis in combination with transgenerational/intergenerational effects.

Results: Maternal and paternal exposures to traditional cardiovascular risk factors during critical temporal windows, including the preconceptional period or early pregnancy, may perturb the plasticity of the epigenome (mainly DNA methylation) of the developing fetus especially at imprinted loci, such as the insulin-like growth factor type 2 (IGF2) gene. Thus, the epigenome is akin to a "molecular archive" able to memorize parental environmental insults and predispose an individual to cardiovascular diseases onset in later life. Direct evidence for human transgenerational epigenetic inheritance (at least three generations) of cardiovascular risk is lacking but it is supported by epidemiological studies. Several blood-based association studies showed potential intergenerational epigenetic effects (single-generation studies) which may mediate the transmittance of cardiovascular risk from parents to offspring.

Discussion: In this narrative review, we discuss some relevant examples of trans- and intergenerational epigenetic associations with cardiovascular risk. In our perspective, we propose three network-oriented approaches which may help to clarify the unsolved issues regarding transgenerational epigenetic inheritance of cardiovascular risk and provide potential early biomarkers for primary prevention.

Citing Articles

Identification and functional characterisation of DNA methylation differences between East- and West-originating Finns.

Ciantar J, Marttila S, Rajic S, Kostiniuk D, Mishra P, Lyytikainen L Epigenetics. 2024; 19(1):2397297.

PMID: 39217505 PMC: 11382697. DOI: 10.1080/15592294.2024.2397297.

References
1.
Agha G, Mendelson M, Ward-Caviness C, Joehanes R, Huan T, Gondalia R . Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease. Circulation. 2019; 140(8):645-657. PMC: 6812683. DOI: 10.1161/CIRCULATIONAHA.118.039357. View

2.
Antoun E, Kitaba N, Titcombe P, Dalrymple K, Garratt E, Barton S . Maternal dysglycaemia, changes in the infant's epigenome modified with a diet and physical activity intervention in pregnancy: Secondary analysis of a randomised control trial. PLoS Med. 2020; 17(11):e1003229. PMC: 7643947. DOI: 10.1371/journal.pmed.1003229. View

3.
Barker D, Osmond C, Forsen T, Kajantie E, Eriksson J . Trajectories of growth among children who have coronary events as adults. N Engl J Med. 2005; 353(17):1802-9. DOI: 10.1056/NEJMoa044160. View

4.
Bauer T, Trump S, Ishaque N, Thurmann L, Gu L, Bauer M . Environment-induced epigenetic reprogramming in genomic regulatory elements in smoking mothers and their children. Mol Syst Biol. 2016; 12(3):861. PMC: 4812527. DOI: 10.15252/msb.20156520. View

5.
Benincasa G, Coscioni E, Napoli C . Cardiovascular risk factors and molecular routes underlying endothelial dysfunction: Novel opportunities for primary prevention. Biochem Pharmacol. 2022; 202:115108. DOI: 10.1016/j.bcp.2022.115108. View